58 related articles for article (PubMed ID: 2842537)
21. The correlation between Ca2+ influx and inositol 1, 4, 5-trisphosphate (IP3) formation in platelets stimulated by various agonists.
Uemura Y; Sakon M; Kawasaki T; Shiba E; Kambayashi J; Mori T
Biochem Int; 1990; 20(5):853-61. PubMed ID: 2112382
[TBL] [Abstract][Full Text] [Related]
22. Monitoring of the activation of receptor-operated calcium channels in human platelets.
Alonso MT; Sanchez A; García-Sancho J
Biochem Biophys Res Commun; 1989 Jul; 162(1):24-9. PubMed ID: 2546547
[TBL] [Abstract][Full Text] [Related]
23. Variation in cytoplasmic calcium increase in platelets as a normal response in healthy persons.
Pedersen OS; Reichelt KL
Scand J Clin Lab Invest; 1998 Oct; 58(6):485-9. PubMed ID: 9832340
[TBL] [Abstract][Full Text] [Related]
24. Modulation of cytoplasmic calcium in human platelets by the phospholipid platelet-activating factor 1-O-alkyl-2-acetyl-SN-glycero-3-phosphorylcholine.
Valone FH; Johnson B
J Immunol; 1985 Feb; 134(2):1120-4. PubMed ID: 2578151
[TBL] [Abstract][Full Text] [Related]
25. Platelet-activating factor stimulates phosphoinositide turnover in neurohybrid NCB-20 cells: involvement of pertussis toxin-sensitive guanine nucleotide-binding proteins and inhibition by protein kinase C.
Yue TL; Stadel JM; Sarau HM; Friedman E; Gu JL; Powers DA; Gleason MM; Feuerstein G; Wang HY
Mol Pharmacol; 1992 Feb; 41(2):281-9. PubMed ID: 1311408
[TBL] [Abstract][Full Text] [Related]
26. Two distinct Ca2+ compartments show differential sensitivity to thrombin, ADP and vasopressin in human platelets.
López JJ; Redondo PC; Salido GM; Pariente JA; Rosado JA
Cell Signal; 2006 Mar; 18(3):373-81. PubMed ID: 16095882
[TBL] [Abstract][Full Text] [Related]
27. Defect in regulation of Ca2+ movement in platelets from patients with systemic lupus erythematosus.
Cheng HH; Ho CM; Huang CJ; Hsu SS; Jiann BP; Chen JS; Huang JK; Chang HT; Lo YK; Yeh JH; Jan CR
Pharmacology; 2005 Mar; 73(4):169-74. PubMed ID: 15591819
[TBL] [Abstract][Full Text] [Related]
28. Platelets as a model for studying the action of antihypertensive drugs.
Menshikov MYu ; Avdonin PV; Kravchenko AN; Nekrasova AA; Mazaev AV; Shkhvatsabaya IK
Health Psychol; 1988; 7 Suppl():75-88. PubMed ID: 3243225
[TBL] [Abstract][Full Text] [Related]
29. Desensitization of platelet-activating factor-stimulated protein phosphorylation in platelets.
Shukla SD; Morrison WJ; Dhar A
Mol Pharmacol; 1989 Apr; 35(4):409-13. PubMed ID: 2539556
[TBL] [Abstract][Full Text] [Related]
30. Platelets in patients with homozygous familial hypercholesterolemia are sensitive to Ca(2+)-mobilizing activity of low density lipoproteins.
Bochkov VN; Matchin YG; Fuki IV; Lyakishev AA; Tkachuk VA
Atherosclerosis; 1992 Oct; 96(2-3):119-24. PubMed ID: 1334652
[TBL] [Abstract][Full Text] [Related]
31. Effect of protopine on cytosolic Ca2+ in rabbit platelets.
Shen ZQ; Chen ZH; Duan L
Zhongguo Yao Li Xue Bao; 1999 Apr; 20(4):338-40. PubMed ID: 10452120
[TBL] [Abstract][Full Text] [Related]
32. [Elevation of intraplatelet free Ca2+ in primary hypertension in man and the rat].
Le Quan Sang KH; Benlian P; Duval C; Montenay-Garestier T; Meyer P; Devynck MA
Arch Mal Coeur Vaiss; 1985 Oct; 78(11):1730-3. PubMed ID: 3938248
[TBL] [Abstract][Full Text] [Related]
33. [Blocking with phorbol ester, a protein kinase C activator, of receptor-dependent platelet calcium channels].
Avdonin PV; Altukhova IP
Biokhimiia; 1985 Aug; 50(8):1235-40. PubMed ID: 2416359
[TBL] [Abstract][Full Text] [Related]
34. Platelet-activating factor stimulation of tyrosine kinase and its relationship to phospholipase C in rabbit platelets: studies with genistein and monoclonal antibody to phosphotyrosine.
Dhar A; Paul AK; Shukla SD
Mol Pharmacol; 1990 Apr; 37(4):519-25. PubMed ID: 1691437
[TBL] [Abstract][Full Text] [Related]
35. Effect of platelet agonists on the binding of platelet-activating factor to human platelets.
Burgers JA; Akkerman JW
J Lipid Mediat; 1992 Sep; 5(3):289-300. PubMed ID: 1334723
[TBL] [Abstract][Full Text] [Related]
36. Alterations of cytosolic calcium in platelets and erythrocytes of Lyon hypertensive rats.
Zicha J; Pernollet MG; Kunes J; Lacour B; Vincent M; Sassard J; Devynck MA
Am J Hypertens; 1995 Aug; 8(8):842-9. PubMed ID: 7576402
[TBL] [Abstract][Full Text] [Related]
37. Modulation of receptor-dependent increase of calcium ions in human platelets by taurine.
Atahanov SE; Elizarova EP
Arzneimittelforschung; 1992 Nov; 42(11):1311-3. PubMed ID: 1492843
[TBL] [Abstract][Full Text] [Related]
38. Identification and function of the high affinity binding sites for Ca2+ on the surface of platelets.
Brass LF; Shattil SJ
J Clin Invest; 1984 Mar; 73(3):626-32. PubMed ID: 6231306
[TBL] [Abstract][Full Text] [Related]
39. Platelet-activating factor-induced calcium mobilization in human platelets and neutrophils: effects of PAF-acether antagonists.
Selak MA; Smith JB
J Lipid Mediat; 1989; 1(2):125-37. PubMed ID: 2519888
[TBL] [Abstract][Full Text] [Related]
40. LDL- and agonist-induced Ca(2+)-mobilization in platelets of healthy subjects and in patients with familial hyperlipoproteinemia type II.
Bochkov VN; Rozhkova TA; Matchin YuG ; Lyakishev AA; Bochkova NA; Borisova YuL ; Kukharchuk VV; Tkachuk VA
Thromb Res; 1991 Feb; 61(4):403-9. PubMed ID: 2063348
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
